Industry Insight

Axendia Report: Digital CQV – A Strategic Advantage for Life Sciences

Industry Insight: Axendia Report: Digital CQV – A Strategic Advantage for Life Sciences

AI, cloud, and Computer Software Assurance (CSA) are changing how life sciences companies think about validation, but scanning paper to PDFs isn’t digital transformation—it’s paper-on-glass. Axendia’s Voice of the Customer report presented by Valgenesis shows how leaders are using fully digital commissioning, qualification, and validation (CQV) to cut cycle times, strengthen compliance, and get AI-ready.

 

Based on real-world experiences from Transcat, Rottendorf Pharma, and Otsuka, you’ll see how organizations are:

   · Moving beyond “paper-on-glass” to structured, system-native validation data

   · Reducing validation cycle times by up to 50% and CSV effort by up to 40%

   · Improving audit readiness with end-to-end traceability and secure e-signatures

   · Lowering delivery costs while winning larger projects and boosting client retention

   · Laying the groundwork for AI-native validation and smarter risk-based decisions

 

Download the report to learn how digital CQV turns validation from a cost center into a competitive advantage.

Written by:

Read Your Industry Insight